This activity from myCME offers a review of groundbreaking molecular research and novel treatment options for patients with NSCLC.
Patients undergoing chemotherapy for hematologic cancers are at risk for this complication. The review can help you learn how to assess their risk.
A primer on what nurses need to know when scheduling items and services for patients participating in clinical trials.
Learn how patients' perceptions of health care can have a significant influence on the effectiveness of cancer care and patient education.
The CD20 antagonist is a potentially effective preventive and treatment for this common adverse effect of hematopoietic stem cell transplantation.
Signs and symptoms of venous thromboembolism in oncology patients should be heeded with prompt therapeutic and mechanical interventions.
This review describes the four major groups of leukemia, plus diagnostic tests and treatment regimens for each group.
Although the risks of erythropoietin-stimulating agents can outweigh the benefits, select patients may benefit.
VADs enable long-term IV therapy; however, the devices and their use pose a unique set of challenges for nurses.
Audiometric testing, awareness of the symptoms, and knowledge of which drugs are ototoxic can help protect young cancer patient's hearing.
From the August 2012 issue of The Clinical Advisor: Infections, tumors, and lumps affecting the scrotal content. A lump, enlarging scrotum or pain can conjure up images of testicular cancer, but other conditions involving the scrotal content are possible.
From the June 2012 issue of The Clinical Advisor: Oral Involvement of Systemic Diseases. Oral manifestations are often an early signal of systemic disease, so recognizing them can point the way to a prompt diagnosis.
New treatment options for multiple myeloma (MM) have led to improvements in response rates and patient survival.
Longer-term 10-year survival rates that approach 59% in adults and 75% are increasing the percentage of patients with cancer who outlive their disease. Cancer survivors have poorer health outcomes across multiple measures after the diagnosis of cancer than do noncancer pain patients, and psychosocial difficulties in cancer survivors can significantly...
Medications are used extensively to manage pain and nonpain symptoms associated with advanced illness. It is imperative that practitioners be knowledgeable about new drugs and dosage formulations introduced to the market. Participants learn about the indications, dosing, adverse effects, drug interactions, and appropriate use of new analgesics and other medications...
myCME.com offers over 50 oncology activities. Click here to view them all.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|